Recent Updates
Recently added Catalysts
ELAN

Elanco Animal Health 2500 Innovation Way Greenfield, IN 46140 FOR IMMEDIATE RELEASE Media: Colleen Parr Dekker +1.317.989.7011 colleen_parr_dekker@elanco.com Investor Relations: Tiffany Kanaga +1.302.897.0668 kanaga_tiff

Key Takeaway: Media: Colleen Parr Dekker +1.317.989.7011 colleen_parr_dekker@elanco.com Investor Relations: Tiffany Kanaga +1.302.897.0668 kanaga_tiffany@elanco.com Elanco General Counsel Michael-Bryant Hicks to Depart After Successful Company Stand-Up and Acquisition Completion GREENFIELD

Full Press Release Details

Media: Colleen Parr Dekker +1.317.989.7011 colleen_parr_dekker@elanco.com
Investor Relations: Tiffany Kanaga +1.302.897.0668 kanaga_tiffany@elanco.com
Elanco General Counsel Michael-Bryant
Hicks to Depart After Successful Company Stand-Up and Acquisition Completion
GREENFIELD, Ind. (February 22, 2021) Elanco
Animal Health Incorporated (NYSE: ELAN) today announced the departure of executive vice president Michael-Bryant Hicks ("Hicks").
He joined Elanco in 2018 as General Counsel and Corporate Secretary to prepare the company for IPO, build the Legal department
structure for the stand-alone company, and complete the successful acquisition of Bayer Animal Health.
"I am grateful to Hicks for his contributions to Elanco,
providing the legal expertise we needed to successfully transform into a stand-alone animal health company while completing the
industry's biggest acquisition," said Jeff Simmons, president and CEO at Elanco. "His skill set is unique, and
I fully support his aspiration to lead other companies through the same type of dynamic transformation Elanco's undertaken."
Hicks will depart Elanco on March 2 and the process to
backfill the role is currently underway.
"The last three years at Elanco have been some of the
most rewarding in my career, with the opportunity to work alongside talented teammates and make significant contributions in the
company's formative years," said Michael-Bryant Hicks. "I'm looking forward to taking this experience forward
to help others navigate these same types of exciting opportunities."
Elanco Animal Health Incorporated (NYSE: ELAN) is a global
leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals
and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of
animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making
a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching
Life and our Elanco Healthy Purpose Sustainability/ESG Pledges - all to advance the health of animals, people and
the planet. Learn more at www.elanco.com.
Last updated: Feb 22, 2021